Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1651–1700 of 75328
directors Robert Y. Clagett and Charles A. Kabbash did not stand for re-election at the annual meeting of stockholders held on May 21, 2026
the Board appointed Scott R. Gamble to the Company and Bank boards
directors Robert Y. Clagett and Charles A. Kabbash did not stand for re-election at the annual meeting of stockholders held on May 21, 2026
On May 20, 2026, the Board of Directors (the “Board”) of Integral Technologies Inc. (the “Company”) appointed Michael Pruitt to serve as a member of the Board.
On May 20, 2026, the Board of Directors of The Honest Company, Inc. (the “Company”) approved the promotion of Curtiss Bruce to the position of Chief Financial & Operating Officer, effective May 21, 2026 (the “Effective Date”).
On May 20, 2026, Stacia Hansen, the Chief Accounting Officer and Treasurer of the Company, submitted her resignation and the Board accepted such resignation. The effective date of Ms. Hansen's resignation as Chief Accounting Officer is expected to be June 12, 2026.
On May 26, 2026, the Board of Directors (the “Board”) of Arq, Inc. (the “Company”) appointed Shimon Steinmetz, 48, as the Company’s Executive Vice President and Chief Financial Officer, effective as of his commencement date which will be on or prior to July 27, 2026.
Effective as of June 1, 2026, the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”), following the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Company’s Board from ten to eleven and elected Benjamin F. Cravatt, Ph.D. to fill the newly created vacancy.
the Board elected Joseph Haniford as a director of the Company, effective immediately.
each of Mr. Freeman and Mr. Tack tendered his respective resignation to the Nominating and Governance Committee
each of Mr. Freeman and Mr. Tack tendered his respective resignation to the Nominating and Governance Committee
On May 27, 2026, the Company announced that David J. Pauli, who currently serves as Chief Financial Officer (CFO), was promoted to the position of Chief Operating Officer (COO), effective immediately.
The Company also announced that Daniel J. Klun was promoted to the position of CFO.
On May 27, 2026, the Board of Directors (the “Board”) of Fortress Value Acquisition Corp. V (the “Company”) appointed Karen Park to serve as a director of the Company, effective immediately.
There are no arrangements or understandings between Mr. Cohn and any other person pursuant to which Mr. Cohn was appointed as a director
On May 25, 2026, the Board of Directors (the “ Board ”) of the Company appointed Pankaj Malik, who currently serves as the Company’s Chief Accounting Officer, as the Company's Interim Chief Financial Officer, effective as of May 29, 2026.
Effective May 22, 2026, the Board of Directors (the “Board”) of Zentalis Pharmaceuticals, Inc. (the “Company”) increased its size from six to seven directors and appointed Shannon Campbell, as a Class I director.
As previously disclosed, on March 5, 2026, Rodney Gonsalves, informed the Company that he would retire from his position as the Company’s Vice President, Corporate Controller and Principal Accounting Officer, the exact date to be determined at a later time.
On May 20, 2026, the Company appointed Tim Downs as the new Vice President, Chief Accounting Officer of the Company and as principal accounting officer of the Company, effective as of the first business day following the Company’s filing of the quarterly report on Form 10-Q for the quarter ended April 30, 2026 (the “Start Date”).
On May 20, 2026, in connection with the IPO, each of Joseph Durnford, Ernest Miller, Jon Ryan, Mike Maggard, Dan Collingridge-Padbury and Jonathan Nickell (collectively, the “ Directors ”) was appointed to the board of directors of the Company (the “ Board ”).
On May 20, 2026, in connection with the IPO, each of Joseph Durnford, Ernest Miller, Jon Ryan, Mike Maggard, Dan Collingridge-Padbury and Jonathan Nickell (collectively, the “ Directors ”) was appointed to the board of directors of the Company (the “ Board ”).
On May 20, 2026, in connection with the IPO, each of Joseph Durnford, Ernest Miller, Jon Ryan, Mike Maggard, Dan Collingridge-Padbury and Jonathan Nickell (collectively, the “ Directors ”) was appointed to the board of directors of the Company (the “ Board ”).
On May 20, 2026, in connection with the IPO, each of Joseph Durnford, Ernest Miller, Jon Ryan, Mike Maggard, Dan Collingridge-Padbury and Jonathan Nickell (collectively, the “ Directors ”) was appointed to the board of directors of the Company (the “ Board ”).
On May 20, 2026, in connection with the IPO, each of Joseph Durnford, Ernest Miller, Jon Ryan, Mike Maggard, Dan Collingridge-Padbury and Jonathan Nickell (collectively, the “ Directors ”) was appointed to the board of directors of the Company (the “ Board ”).
On May 20, 2026, in connection with the IPO, each of Joseph Durnford, Ernest Miller, Jon Ryan, Mike Maggard, Dan Collingridge-Padbury and Jonathan Nickell (collectively, the “ Directors ”) was appointed to the board of directors of the Company (the “ Board ”).
On May 21, 2026, the remaining members of the Board of Directors of the Company appointed Richard Xie to the Company’s Board of Directors, effective immediately, to fill the vacancy created by Mr. Rossetti’s resignation.
On May 21, 2026, Joseph F. Rossetti notified ESG Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors, effective immediately.
On May 22, 2026, Timothy A. Massa, the Executive Vice President and Associate Experience Officer of The Kroger Co. (the “Company”), provided notice to the Company of his intention to retire in the fall of 2026.
on May 26, 2026, by the Company’s current CFO, Kenneth Krause, to pursue another opportunity, effective as of the CFO Transition Date
the Board of Directors (the “Board”) of Rollins, Inc. (the “Company”) approved the appointment of William Harkins, who is currently the Company’s Chief Accounting Officer (“CAO”), to also become the Company’s Executive Vice President and Chief Financial Officer (“CFO”), effective June 15, 2026
The Company’s Interim Chief Executive Officer, C. Thomas Evans, Jr., will return to his role as the Company’s Executive Vice President, Secretary, and General Counsel.
appointed Stephen J. McAnena as the Company’s President and Chief Executive Officer and as a member of the Board, in each case, effective June 1, 2026
the Board elected Tony DeSantis to the Board to serve as a non-employee director, effective as of the Effective Date.
the Board of Directors (the "Board") of the Company approved the appointment of Tom Javitch to serve as the Company’s Interim Chief Financial Officer
Ms. Boratto provided notice of her intent to resign from the Company to pursue another professional opportunity, effective as of the Transition Date, on May 20, 2026.
On May 22, 2026 (the “Effective Date”), Immunic, Inc. (the "Company") appointed Erik Lundgren, as Chief Executive Officer of the Company, with his start of employment beginning on June 1, 2026.
On May18, 2026, Debra Bigman informed the Board of Directors of Internet Sciences Inc. (the “Company”) of her decision not to stand for re-election to the Company’s Board of Directors upon expiration of her current term, which expires at the Company’s 2026 Annual Meeting of Shareholders.
On May 20, 2026, CVB Financial Corp. (the “Company”) received notice that Richard Wohl will retire from his role as Executive Vice President and General Counsel of the Company and its principal subsidiary, Citizens Business Bank, National Association, effective on June 5, 2026.
On May 26, 2026, Mark S. Peek notified the Board of Directors (the “Board”) of Trimble Inc. (the “Company”) that he has resigned from his role as a director of the Board, effective immediately.
On May 14, 2026, Anthony Catalano was appointed as the Chief Operating Officer of Quanterix Corporation (the “Company”).
Michael Miller, formerly the Chief Operating Officer of the Company, has transitioned to a new role as the Chief Technology and Products Officer of the Company.
On May 21, 2026, in connection with the IPO, Shahal M. Khan, Leon Golden, Scott E. Young and Sergey Alekseev were appointed to the board of directors of the Company.
On May 21, 2026, in connection with the IPO, Shahal M. Khan, Leon Golden, Scott E. Young and Sergey Alekseev were appointed to the board of directors of the Company.
On May 21, 2026, in connection with the IPO, Shahal M. Khan, Leon Golden, Scott E. Young and Sergey Alekseev were appointed to the board of directors of the Company.
On May 21, 2026, in connection with the IPO, Shahal M. Khan, Leon Golden, Scott E. Young and Sergey Alekseev were appointed to the board of directors of the Company.
Effective May 19, 2026, Ms. M. Christie Smith and Mr. John W. Oleniczak were appointed to the board of directors of the Company.
Effective May 19, 2026, Ms. M. Christie Smith and Mr. John W. Oleniczak were appointed to the board of directors of the Company.
On May 20, 2026, the Board appointed Nicholas Johnson, age 46, to serve as Chief Executive Officer of the Company, effective June 1, 2026.
On May 19, 2026, Christopher P. Litterio, General Counsel, Secretary, and Senior Vice President of Human Resources, informed UFP Technologies, Inc., a Delaware corporation (the “ Company ”), that he plans to retire from the Company after a period of transition .
On May 19, 2026, the Board of the McCormick & Company, Incorporated (the “Company”) appointed Cindy Hoots to the Board of the Company with effect from June 1, 2026
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.